The prognostic value of KRAS mutation subtypes and PD-L1 expression in patients with lung adenocarcinoma.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: AdventHealth Orlando, AdventHealth
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2946918722
